Literature DB >> 11278106

Complement inhibition does not reduce post-hypoxic-ischemic cerebral injury in 21-day-old rats.

H A Lassiter1, R C Feldhoff, N Dabhia, J C Parker, P W Feldhoff.   

Abstract

Hypoxic-ischemic (HI) cerebral injury frequently follows resuscitation and is a recognized cause of permanent long-term neurologic disability in children. Complement activation has been shown to participate in post-ischemic injury to a variety of tissues and organs. To test the hypothesis that complement activation participates in post-HI cerebral injury in immature rats, 21-day-old rats were subjected to right common carotid artery ligation and 8% O(2). This combination of ischemia and hypoxia resulted in the development of significant neuronal loss, edema, and atrophy in the right cerebral hemisphere. However, intraperitoneal administration of the complement inhibitors soluble complement receptor type 1 or cobra venom factor did not reduce the neuronal loss, edema, or atrophy. Therefore, complement activation did not contribute significantly to the cerebral injury observed in this immature rat model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278106     DOI: 10.1016/s0304-3940(01)01653-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

2.  The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.

Authors:  Maria Grazia De Simoni; Emanuela Rossi; Claudio Storini; Simone Pizzimenti; Cinara Echart; Luigi Bergamaschini
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

3.  Systemic complement activation following human acute ischaemic stroke.

Authors:  E D Pedersen; U Waje-Andreassen; C A Vedeler; G Aamodt; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 4.  Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis.

Authors:  Franca Orsini; Daiana De Blasio; Rosalia Zangari; Elisa R Zanier; Maria-Grazia De Simoni
Journal:  Front Cell Neurosci       Date:  2014-11-07       Impact factor: 5.505

Review 5.  Antimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damage.

Authors:  Eridan Rocha-Ferreira; Mariya Hristova
Journal:  Front Immunol       Date:  2015-02-12       Impact factor: 7.561

6.  Imaging of activated complement using ultrasmall superparamagnetic iron oxide particles (USPIO)--conjugated vectors: an in vivo in utero non-invasive method to predict placental insufficiency and abnormal fetal brain development.

Authors:  G Girardi; J Fraser; R Lennen; R Vontell; M Jansen; G Hutchison
Journal:  Mol Psychiatry       Date:  2014-09-23       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.